Français Register Login

  • All sections
  • A - Human necessities
  • A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
  • A61P 31/14 - Antivirals for RNA viruses

Patent holdings for IPC class A61P 31/14

Total number of patents in this class: 12434

10-year publication summary

119
131
236
333
359
1433
1674
2032
1349
829
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Gilead Sciences, Inc.
2070
136
The United States of America, as represented by the Secretary, Department of Health and Human Services
2895
101
The Regents of the University of California
20230
98
Bristol-myers Squibb Company
4848
82
Centre National de La Recherche Scientifique
10635
78
Katholieke Universiteit Leuven
1213
74
Modernatx, Inc.
1297
68
Janssen Pharmaceuticals, Inc.
441
67
Enanta Pharmaceuticals, Inc.
433
65
Emory University
1651
64
Inserm (institut National de La Sante et de La Recherche Medicale)
3367
57
The Trustees of the University of Pennsylvania
4376
52
Vanderbilt University
1928
52
BioNTech SE
716
52
Board of Regents, The University of Texas System
5917
50
Shanghai Institute of Materia Medica, Chinese Academy of Sciences
840
50
Pfizer Inc.
3397
49
The Board of Trustees of the Leland Stanford Junior University
6509
47
Institut Pasteur
784
46
The Wistar Institute of Anatomy and Biology
462
44
Other owners 11102

  • ipowner home
  • ipqwery home
  • contact us
  • privacy policy
  • terms and conditions
© 2025 IPQwery All rights reserved